|
PSMD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.758800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.671600E-02 |
| Normal-vs-Stage2 |
7.584100E-04 |
| Normal-vs-Stage3 |
2.182800E-03 |
| Normal-vs-Stage4 |
3.016000E-04 |
| Stage1-vs-Stage2 |
2.228000E-02 |
| Stage1-vs-Stage3 |
1.139620E-01 |
| Stage1-vs-Stage4 |
2.457800E-02 |
| Stage2-vs-Stage3 |
3.243400E-01 |
| Stage2-vs-Stage4 |
9.074800E-01 |
| Stage3-vs-Stage4 |
3.572600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.159300E-04 |
| Normal-vs-AfricanAmerican |
7.888400E-01 |
| Normal-vs-Asian |
4.752800E-01 |
| Caucasian-vs-AfricanAmerican |
3.649600E-02 |
| Caucasian-vs-Asian |
2.191900E-02 |
| AfricanAmerican-vs-Asian |
7.500000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.992400E-04 |
| Normal-vs-Female |
7.357800E-03 |
| Male-vs-Female |
2.920600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.695900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.839300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.403400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.376300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.862580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.489950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.960630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.773440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.939600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.338000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.681200E-01 |
| Classical-VS-Follicular |
7.617800E-02 |
| Classical-VS-Other |
4.337400E-01 |
| Classical-VS-Normal |
1.861570E-02 |
| Tall-VS-Follicular |
3.801000E-01 |
| Tall-VS-Other |
4.661600E-01 |
| Tall-VS-Normal |
4.387500E-02 |
| Follicular-VS-Other |
8.053000E-01 |
| Follicular-VS-Normal |
2.496300E-03 |
| Other-VS-Normal |
6.569900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.403100E-03 |
| Normal-vs-N1 |
1.004260E-03 |
| N0-vs-N1 |
3.351600E-01 |
|
|
